Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Initial psycho-oncological contact for adults with cancer

Official title: The Impact of a Standardised Initial Contact by a Psycho-oncological Counsellor on Anxiety and Depression, Quality of Life and the Use of Psycho-oncological Support in Cancer Patients: A Patient-initiated Multicentre Randomised Controlled Study - the Psycho-oncological Initial Contact Study (PICS)

Run by Lindenhofgruppe AG · NCT07544446 · Data updated 2026-11-12

This study tests whether an initial psycho-oncological consultation helps reduce anxiety and depression and improve quality of life for adults with cancer.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment148 (estimated)
SponsorLindenhofgruppe AG
Industry-sponsored
Drugs / interventionsCAR-T, chemotherapy, immunotherapy
Locations5 sites (Basel and 4 other locations)
StatusRecruiting
StartedAugust 25, 2026
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedSeptember 2, 2026
Trial IDNCT07544446 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with a diagnosed cancer starting or ongoing systemic or radiotherapy, who have no prior psycho-oncological contact and can consent and complete follow-up.

Probably not a fit

Patients who receive standard care or those with factors limiting benefit (e.g., severe ECOG impairment, language barriers, or inability to participate in follow-up) may not experience a measurable improvement.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with cancer who start or are receiving cancer treatment are randomized to receive either a detailed initial psycho-oncology consultation plus standard care or standard care alone. The study tracks anxiety, depression, and quality of life using questionnaires at the start, 3 months, and 6 months over a 6-month period. It is developed with patient input and conducted across multiple hospitals. The goal is to see if early psycho-oncological contact increases use of support services and improves psychological outcomes.

Why it matters

Potential benefit: If successful, patients may experience lower anxiety and depression and a better quality of life through earlier access to psycho-oncological support.

How similar studies have gone: Previous research in psycho-oncology shows potential benefits of early psychological support, but this specific initial consultation approach is being tested in this multi-center design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with an oncological disease diagnosed within the last 3 months with planned or ongoing systemic oncologic treatment (e.g. chemotherapy, immunotherapy, hormone therapy) or a planned or ongoing radiotherapy
* Patient is ≥18 years of age and legally competent
* Patients must have understood and signed the study information and the informed consent form
* Patients are willing and able to complete scheduled follow-up evaluations / questionnaires as described in the informed consent
* No previous contact with psycho-oncological services

Exclusion Criteria:

* Documented severe functional impairment according to the ECOG Performance Status (ECOG 3-4)
* Patients receiving or planned to receive treatments associated with a severe risk of toxicity (e.g., CAR-T cell therapy, myeloablative therapy)
* Insufficient language skills in German
* Inability to give informed consent
* Refusal to participate in the study, unsigned informed consent

Where it's running

  • Lindenhofgruppe
    Bern, Switzerland
    Recruiting
  • St. Claraspital
    Basel, Switzerland
    Not yet recruiting
  • University Hospital Insel Gruppe AG
    Bern, Switzerland
    Not yet recruiting
  • See-Spital
    Horgen, Switzerland
    Not yet recruiting
  • Klinik für Hämatologie und Onkologie Hirs landen Zürich AG
    Zurich, Switzerland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.